Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
RORγ drives non-small cell lung cancer progression by upregulating the NGF signaling
Yechun Zeng1, Guodi Cai1, Jian Zhang2
1National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong, 510006, China.
Background:
Lung cancer remains one of the most prevalent and lethal malignancies worldwide, with non-small cell lung cancer (NSCLC) representing the most common subtype-highlighting the critical need for novel therapeutic approaches. The retinoic acid receptor-related orphan receptor gamma (RORγ) has been implicated in various cancers, but its role and mechanism in NSCLC remain unclear.
Methods:
RORγ expression and its correlation with patient prognosis in NSCLC were assessed by integrating public database bioinformatics analysis, immunohistochemistry, and Western blot. The functional roles of RORγ in NSCLC proliferation, migration, and invasion were determined in vitro through genetic overexpression, pharmacological inhibition, or genetic silencing of RORγ, assessed by cell counting, colony formation, wound healing, and transwell assays. The underlying mechanism was investigated using RNA sequencing, chromatin immunoprecipitation, and rescue experiments with exogenous nerve growth factor (NGF) supplementation or NGF overexpression. In vivo, the anti-tumor efficacy of RORγ inhibition was evaluated using subcutaneous xenograft and experimental metastasis models.
Results:
We identify RORγ as a key driver of NSCLC progression. Integrative bioinformatics and immunohistochemical analysis revealed that RORγ is highly expressed in NSCLC tissues and that its expression correlates with poor patient prognosis. Functionally, elevated RORγ significantly enhanced the proliferation, migration, and invasion capabilities of NSCLC cells. Conversely, treatment with the RORγ antagonist or genetic silencing of RORγ potently suppressed these malignant phenotypes both in vitro and in vivo. Mechanistically, RORγ directly binds to the promoter region of NGF, stimulates NGF gene transcription, and thereby promotes NSCLC progression. RORγ antagonists suppress NGF expression and inhibit its downstream signaling pathways, whereas exogenous NGF supplementation or overexpression of NGF notably reverses the inhibitory effects of RORγ antagonists on NSCLC cells.
Conclusion:
Taken together, these results establish RORγ as a critical regulator of NSCLC and a promising therapeutic target for NSCLC treatment.
Insights
Retinoic acid receptor-related orphan receptor gamma (RORγ) drives non-small cell lung cancer (NSCLC) progression by promoting cell proliferation and metastasis. Inhibiting RORγ, a key regulator, offers a promising therapeutic strategy for NSCLC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide.
- Novel therapeutic targets are urgently needed for effective NSCLC treatment.
- The role of retinoic acid receptor-related orphan receptor gamma (RORγ) in NSCLC remains largely undetermined.
Purpose of the Study:
- To investigate the role and mechanism of RORγ in the progression of NSCLC.
- To evaluate RORγ as a potential therapeutic target for NSCLC.
Main Methods:
- Bioinformatics analysis, immunohistochemistry, and Western blot were used to assess RORγ expression in NSCLC.
- In vitro and in vivo assays were performed to determine the functional roles of RORγ in NSCLC proliferation, migration, and invasion.
- RNA sequencing, ChIP, and rescue experiments were employed to elucidate the underlying molecular mechanism involving nerve growth factor (NGF).
Main Results:
- RORγ is highly expressed in NSCLC and correlates with poor patient prognosis.
- Elevated RORγ enhances NSCLC cell proliferation, migration, and invasion.
- RORγ directly upregulates NGF transcription, promoting NSCLC progression; RORγ inhibition suppresses tumor growth and metastasis.
Conclusions:
- RORγ is a critical driver of NSCLC progression.
- Targeting RORγ represents a promising therapeutic strategy for NSCLC treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
What is Cell Signaling?
Cell-surface Signaling
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Lung Capacity
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...

